SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agenus (AGEN)
An SI Board Since January 2004
Posts SubjectMarks Bans Symbol
145 19 0 AGEN
Emcee:  Area51 Type:  Unmoderated
AGEN is an interesting company deserving of some discussion\investment consideration in my opinion.

Worthwhile article on the company and to the workings of wall street (piper Jaffrey suspended coverage at 12/01 because it didn't get the secondary offering business)
nyba.org

AGEN is not discussed much on SI, and when it is it is just as likely to be mentioned on the biotech short thread as it is to be mentioned favorably. But some of the shorts concerns (CFO leaving and Jaffrey coverage suspension) were explained in the above article. Short ratio is rather high at about 20% of the float (12/03).

TA aficionados would probably wait for it to pull back (currently 11.77) or clear resistance at 12.40 to 13. A cross of the 50 day sma over the 200 day sma concurrent with a break of resistance might provide a good entry point.
stockcharts.com[l,a]dacanyay[pb50!b200!f][vc60][iUc20!Ll14]&pref=G
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
145Have you read the MiNK Earnings transcript? Phrases like "compelling dataKirk ©-May 14
144You have to hope the Ligand sharks bring more to the table than just cash. Mr. Kirk ©1May 8
143True. I think not a great deal for AGEN. One take I saw was that AGEN sold $400Area51-May 8
142A quick look at www.ligand.com gives me visions of Mark Cuban and Mister WonderKirk ©-May 7
141Interesting news that has not found its way to Agenus's web site but appearsKirk ©-May 7
140You and me both! Of course, if we KNEW a stock would double or triple so quicklKirk ©-April 29
139Price action has been wild since the reverse split. First down but now up fairlyArea51-April 29
138BTW, have you looked at their MiNK spin-off? I think they still hold over 75% oKirk ©-March 4
137Hard to say what the reverse split will mean other than it keeps them off the piKirk ©-March 4
136I hadn't looked at AGEN in years. The drug prospects still look pretty good Area51-March 4
135Great news! Agenus Receives Fast Track Designation for Botensilimab and BalstiliKirk ©14/17/2023
134Agenus Shows Unprecedented Activity for Botensilimab/Balstilimab Combination in Kirk ©16/29/2022
133Agenus Gets FDA Priority Review of Balstilimab in Cervical Cancer DJ REALTIME Kirk ©-6/17/2021
132New Clinical Responses for AGEN1181 Presented at AACR April 10, 2021 Download PKirk ©-4/11/2021
131Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVIKirk ©-2/4/2021
130Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab Kirk ©16/22/2020
129More Good News: ASCO Presentation of Agenus' AGEN1181 by Dr. Steven O'DKirk ©-5/29/2020
128I wasn't aware their cancer therapy would also help with COVID-19, but it maKirk ©-5/13/2020
127It is great to see good news move the stock! First QS-21 Royalty Payment Due toKirk ©-3/10/2020
126Agenus Pipeline Slide agenusbio.com [graphic]Kirk ©-1/14/2020
125News Release Issued: Dec 19, 2019 (7:30am EST) Agenus Commences Combination TriKirk ©-12/19/2019
124News Release Issued: Nov 11, 2019 (8:00am EST) Agenus receives $10M from UroGeKirk ©-11/11/2019
123It is interesting how much the side effects vary. I got my 2nd shot last ThursdKirk ©-11/11/2019
122I took the second Shingles shot on Saturday. My reaction was worse than the firsRarebird-9/30/2019
121Too bad the stock price isn't higher with these results.... but I added receKirk ©-8/9/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):